AlphAIAlphAI — Financial news for AI agents
stocktitan.netSEP 151 min read$DOCS

Officer at Doximity (NYSE: DOCS) to sell 2,077 shares

Doximity officer Siddharth Sitaram filed a Rule 144 notice to sell 2,077 shares, valued at $54,043.54, following a stock option exercise. He previously sold 1,770 shares in August and 1,732 shares in July. The company has 127,349,369 shares outstanding.

Original reporting
stocktitan.net
Published Sep 15, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 11:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$DOCS
Neutral
high confidence
Mentioned
$DOCS
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$DOCSNeutralLow
01

Why it matters

The disclosed sale adds a small amount of supply to the market but does not alter Doximity's fundamentals.

02

Market read

Routine insider sale with minimal market impact.

03

What to watch

The officer's prior sales in July and August suggest a pattern of liquidity needs, but no strategic implication.

Relevance 4/10Novelty 4/10Timing: reported Sep 15 2026

Background

Form 4 filings disclose insider transactions; Rule 144 sales require public notice.

Company-level read

Ticker impact

$DOCSNeutralHigh confidence
Context

Officer Siddharth Sitaram filed a Form 4 showing a Rule 144 sale of 2,077 shares valued at $54,043.

Expected impact

No significant impact; price may stay flat.

Evidence & confidence

The transaction size is small relative to market cap and represents a routine insider liquidity event.

Market effects

Sector

None; Doximity operates in digital health recruiting, unaffected by this sale.

Regional

No regional effect; the filing is specific to the company.

Global

Limited; only relevant to investors tracking Doximity.

Counterpoint

What could challenge this read

Some traders may view any insider selling as a negative signal, but the amount is trivial.

Key entities

  • Officer
    Siddharth Sitaram

    Officer of Doximity filing the Rule 144 sale.

  • Company
    Doximity, Inc.

    Digital health professional network listed on NYSE.

Read at source← All news

Related articles

SEP 14
MedAI 8/10

Doximity’s ex-chief revenue officer to pay nearly $500K to SEC: Trial Balance

Doximity's former chief revenue officer, Paul Jorgensen, was ordered to pay $490,000 to the SEC for insider trading. He sold shares based on nonpublic information ahead of negative earnings announcements, avoiding losses and making $2.2 million in profits. Jorgensen was also sentenced to 26 months in prison and ordered to forfeit $2.5 million in a parallel criminal case.

finance.yahoo.com2 min
SEP 8
$DOCSMed

Doximity stock falls as Freedom Capital cuts to hold

Doximity Inc (DOCS) shares dropped 5.6% after Freedom Capital downgraded it to Hold, raising its price target to $27. The company beat Q1 estimates, increased full-year revenue guidance, but lowered EBITDA outlook due to AI investment. Freedom Capital noted strong AI search traction but margin concerns and core business softening.

investing.com1 min
AUG 16
$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 2027 revenue of $156.6 million, up 7% year over year, and adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million. It said AI workflow and scribe usage grew, repurchased $91.6 million of stock, and ended June 30 with $688 million in cash and marketable securities.

aol.com6 min
AUG 14
$DOCSMedAI 8/10

Doximity (DOCS) Q1 2027 Earnings Call Transcript

Doximity (DOCS) reported Q1 FY2027 revenue of $156.6 million, up 7% year over year, with adjusted EBITDA of $74.8 million. The company raised full-year 2027 revenue guidance to $671 million to $681 million and adjusted EBITDA guidance to $309 million to $329 million. It also repurchased $91.6 million of stock and ended June 30 with $688 million cash and marketable securities.

fool.com7 min
AUG 11
$DOCSMed

Doximity Stock Surges in Overnight Trading as Chief Executive Highlights High-Margin AI Tool

Doximity (DOCS) shares jumped in overnight trading after CEO Jeffrey Tangney said the company’s new AI search tool generates over 10 times the revenue versus its operating cost. The stock later closed up 33% on Friday. Doximity reported Q1 revenue of $156.6M and adjusted EBITDA of $74.8M, and raised full-year guidance to $671M-$681M. Wells Fargo later downgraded to underweight.

tikr.com6 min